Literature DB >> 821091

Cystic fibrosis in adolescents and adults.

P Mitchell-Heggs, M Mearns, J C Batten.   

Abstract

Forty-five patients (25 male and 20 female) over 12 years of age with cystic fibrosis have been studied clinically, radiologically and physiologically. Their mean age at the first visit was 17 years; they were followed for a mean period of 4 years and attended at least every six months. The first symptom which developed before the age of five in 42 of the 45 patients was respiratory. Thirty-two of the 45 patients had severe lung disease (Group III) at the start of the study of the seven patients died during the study. Cough and sputum were almost universal, 23 had haemoptyses and eight pneumothoraces. Staphylococcus pyogenes, Haemophilus influenzae and Pseudomonas aeruginosa were the common pathogens isolated from sputum and the increasing prevalence of the latter was again confirmed. Acquisition of the mucoid strain of pseudomonas signified poor prognosis. Established infection was never eradicated. Forty-three patients had evidence of pancreatic insufficiency; in all but one patient the symptoms were mild and five patients abandoned dietary restriction and pancreatin without ill effect. Seven patients had symptoms of partial bowel obstruction (meconium ileus equivalent) but only one required surgical relief. The liver was enlarged in seven patients and the spleen was felt in three. Three patients had diabetes mellitus. The influence of cystic fibrosis on growth and development is reported--the growth spurt is late in the majority but growth failure is not confined to those with severe lung infection or malabsorption and in these circumstances remains unexplained. Mean weight was low in relation to height and puberty was delayed in both sexes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821091

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  23 in total

Review 1.  Growth and growth charts in cystic fibrosis.

Authors:  Leena Patel; Moira Dixon; T J David
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 2.  Energy balance and growth in cystic fibrosis.

Authors:  S A Wootton; J L Murphy; S A Bond; J E Ellis; A A Jackson
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

3.  Glucose tolerance in cystic fibrosis.

Authors:  S Lanng; B Thorsteinsson; G Erichsen; J Nerup; C Koch
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

Review 4.  Rationale of modern dietary recommendations in cystic fibrosis.

Authors:  J M Littlewood; A MacDonald
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

5.  Menarche in pediatric patients with Crohn's disease.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Eric Vittinghoff
Journal:  Dig Dis Sci       Date:  2012-06-29       Impact factor: 3.199

6.  Cystic fibrosis.

Authors:  M B Mearns
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

7.  Update and Review: Cystic Fibrosis.

Authors:  T Brown; E L Schwind
Journal:  J Genet Couns       Date:  1999-06       Impact factor: 2.537

Review 8.  Allergic bronchopulmonary aspergillosis.

Authors:  Richard B Moss
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

9.  Perspectives of longitudinal growth in cystic fibrosis from birth to adult age.

Authors:  G Haeusler; H Frisch; T Waldhör; M Götz
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

10.  Respiratory tract disease and obstructive azoospermia.

Authors:  E Neville; R Brewis; W K Yeates; A Burridge
Journal:  Thorax       Date:  1983-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.